In the latest trading session, Allstate (ALL) closed at $214.52, marking a +1.16% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.62%. Elsewhere, the Dow saw an upswing of 0.58%, while the tech-heavy Nasdaq appreciated by 0.83%.
Shares of the insurer witnessed a gain of 3.15% over the previous month, beating the performance of the Finance sector with its gain of 0.87%, and the S&P 500's gain of 0.8%.
The investment community will be paying close attention to the earnings performance of Allstate in its upcoming release. The company is slated to reveal its earnings on April 29, 2026. On that day, Allstate is projected to report earnings of $7.8 per share, which would represent year-over-year growth of 120.96%. Simultaneously, our latest consensus estimate expects the revenue to be $17.72 billion, showing a 5.49% escalation compared to the year-ago quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $26.16 per share and revenue of $72.84 billion. These totals would mark changes of -24.89% and +7.35%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Allstate. Recent revisions tend to reflect the latest near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, there's been a 2.63% rise in the Zacks Consensus EPS estimate. Allstate presently features a Zacks Rank of #3 (Hold).
In the context of valuation, Allstate is at present trading with a Forward P/E ratio of 8.11. This expresses a discount compared to the average Forward P/E of 10.66 of its industry.
Investors should also note that ALL has a PEG ratio of 0.43 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. Insurance - Property and Casualty stocks are, on average, holding a PEG ratio of 2.04 based on yesterday's closing prices.
The Insurance - Property and Casualty industry is part of the Finance sector. With its current Zacks Industry Rank of 44, this industry ranks in the top 19% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Allstate Corporation (ALL): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).